Invention Grant
- Patent Title: Anti-human TIM-3 antibodies and methods of use thereof
-
Application No.: US15859506Application Date: 2017-12-30
-
Publication No.: US10752688B2Publication Date: 2020-08-25
- Inventor: Yu-Chen Yang , Li-Yu Chen , Chia-Hua Li , Pei-Han Tai , Hong-Kai Chen , Ying-Yung Lok , Chih-Yung Hu , Chien-Tsun Kuan , Chung-Hsiun Wu
- Applicant: Development Center for Biotechnology
- Applicant Address: TW Taipei
- Assignee: DEVELOPMENT CENTER FOR BIOTECHNOLOGY
- Current Assignee: DEVELOPMENT CENTER FOR BIOTECHNOLOGY
- Current Assignee Address: TW Taipei
- Agency: Liang Legal Group, PLLC
- Main IPC: C07K16/00
- IPC: C07K16/00 ; C07K16/28 ; A61P35/00 ; G01N33/574 ; A61K39/00

Abstract:
An anti-human T-cell immunoglobulin domain and mucin domain 3 (TIM-3) antibody, can bind the peptides, comprising the amino-acid sequence RKGDVSL (SEQ ID NO: 9) and/or EKFNLKL (SEQ ID NO: 10) of human TIM-3 protein. The antibody can regulate immune cell activity. The antibody or binding fragment thereof is useful in diagnosis, prognosis, and treatment of cancers that have been reported to express cell-surface TIM-3 such as lung, liver, esophageal cancer and solid tumors.
Public/Granted literature
- US20180186881A1 ANTI-HUMAN TIM-3 ANTIBODIES AND METHODS OF USE THEREOF Public/Granted day:2018-07-05
Information query